4.7 Article

Cancer-induced bone loss and associated pain-related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE-10790

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

Tartrate-resistant acid phosphatase as a marker of bone metastases in patients with breast cancer and prostate cancer

NV Lyubimova et al.

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2004)